Treatment with intravenous immunoglobulins and methylprednisolone may significantly decrease loss of renal function in chronic-active antibody-mediated rejection.

Kasia A SablikMarian C Clahsen-van GroningenCaspar W N LoomanJeffrey DammanMadelon van AgterenMichiel G H Betjes

Published in: BMC nephrology (2019)

More than 60% of patients with c-aABMR with a progressive decline in eGFR respond favorably to treatment with IVIG-MP resulting in a significant improvement of graft survival (Sablik, Am J Transplant 18, 2018).

Keyphrases

small cell lung cancer
high dose
multiple sclerosis
epidermal growth factor receptor
tyrosine kinase
low dose
replacement therapy
free survival